We are live on
!
Find out more
ECM
Ensemble Capital Management Portfolio holdings
AUM
$1.18B
1-Year Est. Return
41.81%
This Fund
S&P 500
This Quarter
Est. Return
+6.13%
1 Year Est. Return
+41.81%
3 Year Est. Return
+36.2%
5 Year Est. Return
+128.75%
10 Year Est. Return
+329.7%
AUM
$457M
AUM Growth
+$27.8M
(+6.5%)
Cap. Flow
+$995K
Cap. Flow
% of AUM
0.22%
Top 10 Holdings %
Top 10 Hldgs %
62.03%
Holding
43
New
4
Increased
18
Reduced
11
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Verisk Analytics
VRSK
|
+$10.8M |
| 2 |
Nike
NKE
|
+$9.3M |
| 3 |
Prestige Consumer Healthcare
PBH
|
+$6.93M |
| 4 |
Ferrari
RACE
|
+$5.35M |
| 5 |
Landstar System
LSTR
|
+$5.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Warner Bros
WBD
|
+$20.8M |
| 2 |
TransDigm Group
TDG
|
+$12.8M |
| 3 |
NOV
NOV
|
+$8.48M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$6.92M |
| 5 |
Apple
AAPL
|
+$3.12M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.41% |
| 2 | Financials | 18.93% |
| 3 | Industrials | 16.64% |
| 4 | Consumer Discretionary | 12.14% |
| 5 | Communication Services | 5.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
CVS Health
CVS
$120B
| $1.58M | 0.35% |
19,705
-3,070
| -13% | -$242K |
|
|
27
Alphabet (Google) Class C
GOOG
$4.19T
| $1.45M | 0.32% |
31,940
-17,800
| -36% | -$815K |
|
28
Intel
INTC
$493B
| $985K | 0.22% |
29,194
-5,960
| -17% | -$213K |
|
29
Chevron
CVX
$386B
| $919K | 0.2% |
8,810
-500
| -5% | -$53K |
|
|
CERN
30
DELISTED
Cerner Corp
CERN
| $784K | 0.17% |
11,800
-1,030
| -8% | -$65.8K |
|
31
Blackrock
BLK
$178B
| $648K | 0.14% |
1,535
+800
| +109% | +$319K |
|
32
ExxonMobil
XOM
$657B
| $449K | 0.1% |
5,565
| – | – |
|
33
Microsoft
MSFT
$3.74T
| $352K | 0.08% |
+5,111
| New | +$351K |
|
34
Weyerhaeuser
WY
$18B
| $350K | 0.08% |
10,450
| – | – |
|
35
Air Products & Chemicals
APD
$68.9B
| $286K | 0.06% |
2,000
| – | – |
|
|
PXD
36
DELISTED
Pioneer Natural Resource Co.
PXD
| $239K | 0.05% |
+1,500
| New | +$256K |
|
|
37
NOV
NOV
$7.49B
| – | – |
-211,470
| Closed | -$8.48M |
|
38
Plains All American Pipeline
PAA
$16.3B
| – | – |
-9,100
| Closed | -$288K |
|
39
Schwab International Equity ETF
SCHF
$68.5B
| – | – |
-55,120
| Closed | -$823K |
|
40
Schwab US Large- Cap ETF
SCHX
$74.3B
| – | – |
-39,840
| Closed | -$374K |
|
41
Sarepta Therapeutics
SRPT
$1.92B
| – | – |
-10,000
| Closed | -$296K |
|
|
42
Warner Bros
WBD
$67.9B
| – | – |
-713,810
| Closed | -$20.8M |
|
|
APC
43
DELISTED
Anadarko Petroleum
APC
| – | – |
-8,500
| Closed | -$527K |
|
Similar funds
SEC
PP
GFS
GCAC
CAM
PRO
D
FTIS
Ensemble Capital Management's Q2 2017 Portfolio in Review
As of Q2 2017, Ensemble Capital Management held 43 positions worth $457M, up 6.5% from $430M the previous quarter. Its ten largest holdings account for 62% of the portfolio.
Ensemble Capital Management's Q2 2017 filing shows 4 new, 18 increased, 11 reduced and 7 closed positions. Its largest new stake was Verisk Analytics: 133,065 shares worth $11.2M. The largest sale was Warner Bros, an estimated $20.8M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 30% a quarter earlier, followed by Financials and Industrials.
- Ensemble Capital Management's largest Q2 2017 buy was Verisk Analytics: 133,065 shares worth $11.2M.
- Ensemble Capital Management added most to Nike in Q2 2017, an estimated $9.3M increase.
- Ensemble Capital Management's biggest Q2 2017 reduction was TransDigm Group, cutting an estimated $12.8M.
- Ensemble Capital Management fully exited Warner Bros in Q2 2017, selling an estimated $20.8M.
- Ensemble Capital Management's ten largest holdings make up 62% of its $457M portfolio in Q2 2017.
- Ensemble Capital Management opened 4 new positions and closed 7 in Q2 2017.
- Ensemble Capital Management's portfolio value rose 6.5% quarter-over-quarter to $457M.
Based on Ensemble Capital Management's 13F filing for Q2 2017, filed 11 Aug 2017.